<SEC-DOCUMENT>0001213900-18-007967-index.html : 20180620
<SEC-HEADER>0001213900-18-007967.hdr.sgml : 20180620
<ACCEPTANCE-DATETIME>20180620171935
ACCESSION NUMBER:		0001213900-18-007967
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20180620
DATE AS OF CHANGE:		20180620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOLIGENIX, INC.
		CENTRAL INDEX KEY:			0000812796
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				411505029
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-225226
		FILM NUMBER:		18910185

	BUSINESS ADDRESS:	
		STREET 1:		29 EMMONS DRIVE
		STREET 2:		SUITE C-10
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		609-538-8200

	MAIL ADDRESS:	
		STREET 1:		29 EMMONS DRIVE
		STREET 2:		SUITE C-10
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DOR BIOPHARMA INC
		DATE OF NAME CHANGE:	20020329

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENDOREX CORP
		DATE OF NAME CHANGE:	19960916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>fs12018a2_soligenix.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM S-1
<TEXT>
Document 1 - file: fs12018a2_soligenix.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>2
<FILENAME>fs12018a2ex4-8_soligenix.htm
<DESCRIPTION>FORM OF WARRANT TO BE ISSUED TO EACH INVESTOR
<TEXT>
Document 2 - file: fs12018a2ex4-8_soligenix.htm

</DOCUMENT>
</SEC-DOCUMENT>